A consensus viewpoint on the role of direct factor Xa inhibitors in the management of cancer-associated venous thromboembolism in the UK

Author:

Cohen Alexander T.1,Benson Gary2,Bradbury Charlotte A.3,Choudhuri Satarupa4,Hutchinson Jones Nathan5,Maraveyas Anthony6,Venugopal Balaji78,Young Annie M.9ORCID,Chapman Chris10,McIntyre Shauna10,Burney Danny10,Pollock Kevin G.10,Morgan Angharad R.11,Gabb Peter D.11,Alikhan Raza1213

Affiliation:

1. Guy’s and St Thomas’ NHS Foundation Trust, King’s College London, London, UK

2. Northern Ireland Haemophilia Comprehensive Care Centre and Thrombosis Unit, Belfast, UK

3. Faculty of Health Sciences, University of Bristol, Bristol, UK

4. Pennine Acute Hospitals NHS Trust, Manchester, UK

5. Royal United Hospitals, Bath, UK

6. Queen’s Centre for Oncology and Haematology, Hull, UK

7. The Beatson West of Scotland Cancer Centre, Glasgow, UK

8. Institute of Cancer Sciences, University of Glasgow, Glasgow, UK

9. Warwick Clinical Trials Unit, University of Warwick, Coventry, UK

10. Bristol Myers Squibb, Uxbridge, UK

11. Health Economics and Outcomes Research Ltd., Cardiff, UK

12. Haemophilia and Thrombosis Centre, University Hospital of Wales, Cardiff, UK

13. Cardiff University School of Medicine, Cardiff, UK

Funder

Pfizer

Publisher

Informa UK Limited

Subject

General Medicine

Reference83 articles.

1. Extended anticoagulation treatment for cancer‐associated thrombosis—Rates of recurrence and bleeding beyond 6 months: A systematic review

2. Venous thromboembolism and prognosis in cancer

3. All-Party Parliamentary Thrombosis Group. Venous thromboembolism (VTE) in cancer patients: cancer, chemotherapy and clots; 2015. Available from: http://apptg.org.uk/wp-content/uploads/2016/12/VTE-in-Cancer-Patients-2015.pdf#:∼:text=Of%20the%20patients%20who%20died%20of%20cancer%20in,underestimate%20of%20the%20true%20scale.%20High%20Risk%20Cancers.

4. Cancer-associated thrombosis

5. Prevention of Venous Thromboembolism in 2020 and Beyond

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3